Trinity stock is trading higher on Tuesday after the company announced results from its pre-pivotal clinical trial for its continuous glucose monitoring system. Trinity Biotech plc (NASDAQ: TRIB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback